Establishing a Link Between Amino Acid Sequences and Self-Associating and Viscoelastic Behavior of Two Closely Related Monoclonal Antibodies

ABSTRACTPurposeTo investigate the underlying cause for the observed differences in self-associating and viscoelastic behavior between two monoclonal antibodies, MAb1, and MAb2.MethodsSeveral mutants were designed by swapping charged residues in MAb1 with those present in MAb2 at their respective positions and vice versa. Rheological analysis was done at low and high shear rates. Dynamic light scattering quantified intermolecular interactions in dilute solutions; sedimentation equilibrium analysis determined the corrected weight average molecular weight (Mwc) to assess the self-associating behavior in high concentration. The molecular charge was estimated from electrophoretic mobility measurements.ResultsReplacing the charged residues in the CDR of MAb1 resulted in a lower Mwc and solution viscosity. The corresponding changes in either just the variable light (VL) or variable heavy (VH) chain showed only a partial decrease in viscosity, whereas changes in both VL and VH chains resulted in a dramatic reduction in viscosity. The converse case where the VL and VH chains of MAb2 were made to look like MAb1 did not self-associate or show increased viscosity.ConclusionsExposed charged residues in the CDR of MAb1 are critical in determining the self-associating and highly viscous behavior observed at high concentrations.

[1]  R. J. Hunter Chapter 2 – Charge and Potential Distribution at Interfaces , 1981 .

[2]  Ariel Fernández,et al.  What factor drives the fibrillogenic association of β‐sheets? , 2005 .

[3]  A. Minton,et al.  Sedimentation equilibrium in macromolecular solutions of arbitrary concentration. II. Two protein components , 1987, Biopolymers.

[4]  P. Baglioni,et al.  Formation of the Dynamic Clusters in Concentrated Lysozyme Protein Solutions , 2010 .

[5]  A. Minton,et al.  Sedimentation equilibrium in macromolecular solutions of arbitrary concentration. I. Self‐associating proteins , 1987, Biopolymers.

[6]  T. Tadros Zeta potential in colloid science. Principles and application : By R.J. Hunter. Colloid Science Monographs, edited by R.H. Ottewill and R.L. Rowell. Academic Press, London, New York, 1981, 400 pp., £35.00 ($84.00). , 1982 .

[7]  Methods of Examination , 1982 .

[8]  A. Mire-Sluis,et al.  Immune responses to therapeutic proteins in humans--clinical significance, assessment and prediction. , 2002, Current pharmaceutical biotechnology.

[9]  A. Minton,et al.  Intermolecular interactions of IgG1 monoclonal antibodies at high concentrations characterized by light scattering. , 2010, The journal of physical chemistry. B.

[10]  B. Haase,et al.  Macromolecular characterization by sedimentation equilibrium in the preparative ultracentrifuge. , 1979, The Journal of biological chemistry.

[11]  D. Xing,et al.  Dynamic Light Scattering Application to Study Protein Interactions in Electrolyte Solutions , 2004, Journal of biological physics.

[12]  Jochem Alsenz,et al.  Protein Aggregates Seem to Play a Key Role Among the Parameters Influencing the Antigenicity of Interferon Alpha (IFN-α) in Normal and Transgenic Mice , 1997, Pharmaceutical Research.

[13]  David Creed,et al.  THE PHOTOPHYSICS AND PHOTOCHEMISTRY OF THE NEAR‐UV ABSORBING AMINO ACIDS–I. TRYPTOPHAN AND ITS SIMPLE DERIVATIVES , 1984 .

[14]  W. F. Harrington Physical Chemistry of Macromolecules.Charles Tanford , 1962 .

[15]  Charles Tanford,et al.  Physical Chemistry of Macromolecules , 1961 .

[16]  I. Teraoka Polymer solutions: An introduction to physical properties , 2002 .

[17]  Steven J Shire,et al.  Reversible self-association increases the viscosity of a concentrated monoclonal antibody in aqueous solution. , 2005, Journal of pharmaceutical sciences.

[18]  Steven J Shire,et al.  Challenges in the development of high protein concentration formulations. , 2004, Journal of pharmaceutical sciences.

[19]  Zhiqiang An,et al.  Therapeutic monoclonal antibodies , 2009 .

[20]  J L Cleland,et al.  The development of stable protein formulations: a close look at protein aggregation, deamidation, and oxidation. , 1993, Critical reviews in therapeutic drug carrier systems.

[21]  Sandeep Yadav,et al.  Factors affecting the viscosity in high concentration solutions of different monoclonal antibodies. , 2010, Journal of pharmaceutical sciences.

[22]  Fred Jacobson,et al.  Protein aggregation and bioprocessing , 2006, The AAPS Journal.

[23]  D. Kalonia,et al.  Ultrasonic rheology of a monoclonal antibody (IgG2) solution: implications for physical stability of proteins in high concentration formulations. , 2007, Journal of pharmaceutical sciences.

[24]  Steven J. Shire,et al.  Mechanisms of aggregate formation and carbohydrate excipient stabilization of lyophilized humanized monoclonal antibody formulations , 2003, AAPS PharmSci.

[25]  Sandeep Yadav,et al.  Specific interactions in high concentration antibody solutions resulting in high viscosity. , 2010, Journal of pharmaceutical sciences.

[26]  J. Schellman,et al.  Electrical double layer, zeta potential, and electrophoretic charge of double‐stranded DNA , 1977, Biopolymers.

[27]  Theodore W Randolph,et al.  Understanding and modulating opalescence and viscosity in a monoclonal antibody formulation. , 2010, Journal of pharmaceutical sciences.

[28]  Frédéric Cardinaux,et al.  Equilibrium cluster formation in concentrated protein solutions and colloids , 2004, Nature.

[29]  J. W. Goodwin,et al.  Viscoelastic properties of concentrated latices. Part 1.—Methods of examination , 1982 .

[30]  S. Shire Current trends in monoclonal antibody development and manufacturing , 2010 .

[31]  R. J. Hunter,et al.  Measurement and Interpretation of Electrokinetic Phenomena (IUPAC Technical Report) , 2005 .

[32]  T. J. Wilson,et al.  Valence and anion binding of bovine ribonuclease A between pH 6 and 8. , 2005, Analytical biochemistry.

[33]  D. Kalonia,et al.  Measurement of fluid viscosity at microliter volumes using quartz impedance analysis , 2004, AAPS PharmSciTech.

[34]  A. Bund,et al.  Viscoelastic properties of low-viscosity liquids studied with thickness-shear mode resonators. , 1998, Analytical chemistry.

[35]  A. Minton Analytical centrifugation with preparative ultracentrifuges. , 1989, Analytical biochemistry.

[36]  Chuanyin Chen,et al.  Use of T4 lysozyme charge mutants to examine electrophoretic models. , 2002, Biophysical chemistry.

[37]  Randall J Mrsny,et al.  Formulation and delivery issues for monoclonal antibody therapeutics. , 2006, Advanced drug delivery reviews.

[38]  John F. Carpenter,et al.  Physical Stability of Proteins in Aqueous Solution: Mechanism and Driving Forces in Nonnative Protein Aggregation , 2003, Pharmaceutical Research.

[39]  Peter Lindner,et al.  Observation of a Large-Scale Superstructure in Concentrated Hemoglobin Solutions by Using Small Angle Neutron Scattering , 2010 .

[40]  R. J. Hunter,et al.  Chapter 3 – The Calculation of Zeta Potential , 1981 .

[41]  M. Ballow,et al.  Safety of intravenous immunoglobulin. , 1993, Archives of neurology.

[42]  Allen P. Minton,et al.  The effect of volume occupancy upon the thermodynamic activity of proteins: some biochemical consequences , 2004, Molecular and Cellular Biochemistry.

[43]  A. Minton,et al.  Influence of macromolecular crowding upon the stability and state of association of proteins: predictions and observations. , 2005, Journal of pharmaceutical sciences.

[44]  I. Krieger,et al.  The Second Electroviscous Effect in Polymer Latices , 1976 .

[45]  Steven J Shire,et al.  Reversible self-association of a concentrated monoclonal antibody solution mediated by Fab-Fab interaction that impacts solution viscosity. , 2008, Journal of pharmaceutical sciences.

[46]  J. W. Goodwin,et al.  Viscoelastic properties of concentrated latices. Part 2.—Theoretical analysis , 1982 .

[47]  Wei Wang,et al.  Antibody structure, instability, and formulation. , 2007, Journal of pharmaceutical sciences.

[48]  D. Kalonia,et al.  Application of high-frequency rheology measurements for analyzing protein-protein interactions in high protein concentration solutions using a model monoclonal antibody (IgG2). , 2006, Journal of pharmaceutical sciences.

[49]  R. J. Hunter Zeta potential in colloid science : principles and applications , 1981 .

[50]  R. Jefferis Glycosylation of Recombinant Antibody Therapeutics , 2008, Biotechnology progress.

[51]  A. Minton Implications of macromolecular crowding for protein assembly. , 2000, Current opinion in structural biology.

[52]  H. Shepard,et al.  Nonequilibrium thermodynamics of membrane-confined electrophoresis. , 2004, Biophysical chemistry.

[53]  D. Svergun,et al.  Absence of equilibrium cluster phase in concentrated lysozyme solutions , 2008, Proceedings of the National Academy of Sciences.